Xiao-lei Xu
109 Baoyu Road
Tanjiagang, 400036, China
Tanjiagang, 400036, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Therapeutic lumbar puncture and lumbar drainage: which is more effective for the management of intracranial hypertension in HIV patients with cryptococcal meningitis? Results of a prospective non-randomized interventional study in China.
Journal: Current medical research and opinion
Published: February 28, 2022
The Effect of Early vs. Deferred Antiretroviral Therapy Initiation in HIV-Infected Patients With Cryptococcal Meningitis: A Multicenter Prospective Randomized Controlled Analysis in China.
Journal: Frontiers in medicine
Published: September 18, 2021
Establishment of a novel scoring model for mortality risk prediction in HIV-infected patients with cryptococcal meningitis.
Journal: BMC infectious diseases
Published: March 09, 2021
Asymptomatic cryptococcal antigenemia in HIV-infected patients: a review of recent studies.
Journal: Chinese medical journal
Published: December 04, 2020
A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections: Study protocol for the optimal early intervention for cryptococcal antigenemia in HIV-infected patients.
Journal: Medicine
Published: October 31, 2020
Timing of antiretroviral therapy for HIV-infected patients with cytomegalovirus retinitis: study protocol of a multi-center prospective randomized controlled trial.
Journal: Trials
Published: September 15, 2020
No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study.
Journal: Frontiers in pharmacology
Published: May 13, 2020
Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol.
Journal: Chinese medical journal
Published: March 10, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026